SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008557
Filing Date
2022-05-12
Accepted
2022-05-12 16:18:57
Documents
87
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fbio-20220331x10q.htm   iXBRL 10-Q 2836516
2 EX-31.1 fbio-20220331xex31d1.htm EX-31.1 13868
3 EX-31.2 fbio-20220331xex31d2.htm EX-31.2 14570
4 EX-32.1 fbio-20220331xex32d1.htm EX-32.1 8231
5 EX-32.2 fbio-20220331xex32d2.htm EX-32.2 8187
  Complete submission text file 0001558370-22-008557.txt   11438112

Data Files

Seq Description Document Type Size
6 EX-101.SCH fbio-20220331.xsd EX-101.SCH 80421
7 EX-101.CAL fbio-20220331_cal.xml EX-101.CAL 85113
8 EX-101.DEF fbio-20220331_def.xml EX-101.DEF 312884
9 EX-101.LAB fbio-20220331_lab.xml EX-101.LAB 593015
10 EX-101.PRE fbio-20220331_pre.xml EX-101.PRE 494480
81 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20220331x10q_htm.xml XML 2309912
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 22918094
SIC: 2834 Pharmaceutical Preparations